On September 2, 2025 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, reported that the time of management’s presentation at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8th – 10th, 2025 in New York City, has been changed to 10:30 AM ET on September 9 (Press release, Anixa Biosciences, SEP 2, 2025, https://ir.anixa.com/news/detail/1096/anixa-biosciences-announces-time-change-for-presentation-at-the-h-c-wainwright-27th-annual-global-investment-conference [SID1234655633]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mike Catelani, President and CFO of Anixa, will deliver a presentation and will be available for one-on-one meetings during the conference.
Details of the presentation are as follows:
Event: H.C. Wainwright 27th Annual Global Investment Conference
Date: September 9, 2025
Time: 10:30 AM ET
Location: Kennedy I – 4th Floor, Lotte New York Palace Hotel
Webcast: View Source